Johnson & Johnson Medtech Sales Miss Expectations Amid Middle East Conflict
What happened
Johnson & Johnson reported that its third-quarter medtech sales missed Wall Street expectations. The company attributed this shortfall to the ongoing conflict in the Middle East. Additionally, Johnson & Johnson announced plans to spin off its orthopedics division, DePuy Synthes, into a separate company in mid-2027.
From investors.com
Why it matters
The conflict in the Middle East impacted Johnson & Johnson's revenue through its medtech segment. The planned spin-off of DePuy Synthes represents a major corporate restructuring move by Johnson & Johnson.
From investors.com
Who's involved
- Johnson & JohnsonCompany reporting third-quarter medtech sales miss and planning a spinoff.
- Middle EastGeopolitical region cited as the cause of sales impact.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Johnson & JohnsonSpeculative
Johnson & Johnson might see its revenue decline due to the impact of the Middle East conflict on its sales.
Keep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Middle East
geopolitical region encompassing Egypt and most of Western Asia, including Iran
Related events
- The conflict in the Middle East has driven up the average sales price for Pem, while North American infrastructure investments are boosting Pem's sales volume.
- Quess Corp reported higher margins driven by performance in the Middle East.
- Conflict in the Middle East is driving up input costs in Gaborone.
- The Middle East conflict is causing a steep decline in fuel oil imports, leading to market pricing dynamics being compared between Fujairah and Singapore.
- Supply chain disruptions in the Middle East are noted alongside a valuation discount relative to KPIL.